Evidence map›Paper›PMID 36342950›Full record

ArticlePloS one2022

Getting funded in a highly fluctuating environment: Shifting from excellence to luck and timing.

Eneli Kindsiko, Kärt Rõigas, Ülo Niinemets

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Eneli KindsikoSchool of Economics and Business Administration, University of Tartu, Tartu, Estonia.ORCID 0000-0001-9466-6070
Kärt RõigasSchool of Economics and Business Administration, University of Tartu, Tartu, Estonia.
Ülo NiinemetsEstonian Academy of Sciences, Tallinn, Estonia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent data highlights the presence of luck in research grant allocations, where most vulnerable are early-career researchers. The national research funding contributes typically the greatest share of total research funding in a given country, fulfilling simultaneously the roles of promoting excellence in science, and most importantly, development of the careers of young generation of scientists. Yet, there is limited supply of studies that have investigated how do early-career researchers stand compared to advanced-career level researchers in case of a national research grant system. We analyzed the Estonian national highly competitive research grant funding across different fields of research for a ten-year-period between 2013-2022, including all the awarded grants for this period (845 grants, 658 individual principal investigators, PI). The analysis was conducted separately for early-career and advanced-career researchers. We aimed to investigate how the age, scientific productivity and the previous grant success of the PI vary across a national research system, by comparing early- and advanced-career researchers. The annual grant success rates varied between 14% and 28%, and within the discipline the success rate fluctuated across years even between 0-67%. The year-to-year fluctuations in grant success were stronger for early-career researchers. The study highlights how the seniority does not automatically deliver better research performance, at some fields, younger PIs outperform older cohorts. Also, as the size of the available annual grants fluctuates remarkably, early-career researchers are most vulnerable as they can apply for the starting grant only within a limited "time window".

Indexed as

Awards and PrizesBiomedical ResearchEfficiencyFinancing, OrganizedHumansResearch PersonnelUnited States

Identifiers

PMID36342950
PMCPMC9639839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.